Structural identification of the pathway of long-range communication in an allosteric enzyme

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 6, 2008, Pages 1832-1837

  Gandhi, Prafull S ^a   Chen, Zhiwei ^a   Mathews, F Scott ^a   Di Cera, Enrico ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Protease activated receptor; Thrombin; X ray crystallography

Indexed keywords

ANION; EXOSITE I; PROTEINASE ACTIVATED RECEPTOR 1; THROMBIN; UNCLASSIFIED DRUG;

ALLOSTERISM; ARTICLE; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; X RAY CRYSTALLOGRAPHY;

ALLOSTERIC REGULATION; AMINO ACID SEQUENCE; BINDING SITES; CATALYSIS; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTAGENESIS; PROTEIN CONFORMATION; RECEPTOR, PAR-1; THROMBIN;

EID: 41149167073     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0710894105     Document Type: Article

References (64)

1. Monod J, Changeux JP, Jacob F (1963) Allosteric proteins and cellular control systems. J Mol Biol 6:306-329.
2. Monod J, Wyman J, Changeux JP (1965) On the nature of allosteric transitions: A plausible model. J Mol Biol 12:88-118.
3. Wyman J, Gill SJ (1990) Binding and Linkage (Univ Science Books, Mill Valley, CA).
4. Perutz MF (1970) Stereochemistry of cooperative effects in haemoglobin. Nature 228:726-739.
5. Changeux JP, Edelstein SJ (2006) Allosteric mechanisms of signal transduction. Science 308:1424-1428.
6. Di Cera E (2006) A structural perspective on enzymes activated by monovalent cations. J Biol Chem 281:1305-1308.
7. Kantrowicz ER, Lipscomb WM (1990) Escherichia coli aspartate transcarbamylase: the molecular basis for a concerted allosteric transition. Trends Biochem Sci 15:53-59.
8. Pellicena P, Kuriyan J (2006) Protein-protein interactions in the allosteric regulation of protein kinases. Curr Opin Struct Biol 16:702-709.
9. Xu Z, Horwich AL, Sigler PB (1997) The crystal structure of the asymmetric GroEL-GroES-(ADP)7 chaperonin complex. Nature 388:741-750.
10. Gunasekaran K, Ma B, Nussinov R (2004) Is allostery an intrinsic property of all dynamic proteins? Prot Struct Funct Genet 57:433-443.
11. Swain JF, Gierasch LM (2006) The changing landscape of protein allostery. Curr Opin Struct Biol 16:102-108.
12. Di Cera E, Page MJ, Bah A, Bush-Pelc LA, Garvey LC (2007) Thrombin allostery. Phys Chem Chem Phys 9:1292-1306.
13. Yu EW, Koshland DE, Jr (2001) Propagating conformational changes over long (and short) distances in proteins. Proc Natl Acad Sci USA 98:9517-9520.
14. Süel GM, Lockless SW, Wall MA, Ranganathan R (2003) Evolutionarily conserved networks of residues mediate allosteric communication in proteins. Nat Struct Biol 10:59-69.
15. Ota N, Agard DA (2007) Intramolecular signaling pathways revealed by modeling anisotropic thermal diffusion. J Mol Biol 351:345-354.
16. Bode W (2006) Structure and interaction modes of thrombin. Blood Cells Mol Dis 36:122-130.
17. Davie EW, Kulman JD (2006) An overview of the structure and function of thrombin. Semin Thromb Hemost 32(Suppl 1):3-15.
18. Dang OD, Vindigni A, Di Cera E (1995) An allosteric switch controls the procoagulant and anticoagulant activities of thrombin. Proc Natl Acad Sci USA 92:5977-5981.
19. + binding to thrombin. J Biol Chem 281:40049-40056.
20. + binding site of thrombin. J Biol Chem 270:22089-22092.
21. + binding to thrombin. J Biol Chem 279:31842-31853.
22. Dang QD, Guinto ER, Di Cera E (1997) Rational engineering of activity and specificity in a serine protease. Nat Biotechnol 15:146-149.
23. Mengwasser KE, Bush LA, Shih P, Cantwell AM, Di Cera E (2005) Hirudin binding reveals key determinants of thrombin allostery. J Biol Chem 280:23997-27003.
24. Liu LW, Vu TK, Esmon CT, Coughlin SR (1991) The region of the thrombin receptor resembling hirudin binds to thrombin and alters enzyme specificity. J Biol Chem 266:16977-16980.
25. Rezaie AR, He X, Esmon CT (1998) Thrombomodulin increases the rate of thrombin inhibition by BPTI. Biochemistry 37:693-699.
26. Rezaie AR, Yang L (2003) Thrombomodulin allosterically modulates the activity of the anticoagulant thrombin. Proc Natl Acad Sci USA 100:12051-12056.
27. Vindigni A, White CE, Komives EA, Di Cera E (1997) Energetics of thrombin-thrombomodulin interaction. Biochemistry 36:6674-6681.
28. Ayala Y, Di Cera E (1994) Molecular recognition by thrombin. Role of the slow→fast transition, site-specific ion binding energetics and thermodynamic mapping of structural components. J Mol Biol 235:733-746.
29. Bode W, Turk D, Karshikov A (1992) The refined 1.9-A X-ray crystal structure of D-Phe-Pro-Arg chloromethylketone-inhibited human alpha-thrombin: Structure analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure-function relationships. Protein Sci 1:426-471.
30. Fuentes-Prior P, et al. (2000) Structural basis for the anticoagulant activity of the thrombin-thrombomodulin complex. Nature 404:518-525.
31. Vijayalakshmi J, Padmanabhan KP, Mann KG, Tulinsky A (1994) The isomorphous structures of prethrombin2, hirugen-, and PPACK-thrombin: changes accompanying activation and exosite binding to thrombin. Protein Sci 3:2254-2271.
32. Bah A, Chen Z, Bush-Pelc LA, Mathews FS, Di Cera E (2007) Crystal structures of murine thrombin in complex with the extracellular fragments of murine protease-activated receptors PAR3 and PAR4. Proc Natl Acad Sci USA 104:11603-11608.
33. Coughlin SR (2000) Thrombin signalling and protease-activated receptors. Nature 407:258-264.
34. Coughlin SR (2005) Protease-activated receptors in hemostasis, thrombosis and vascular biology. J Thromb Haemost 3:1800-1814.
35. Nakanishi-Matsui M, et al. (2000) PAR3 is a cofactor for PAR4 activation by thrombin. Nature 404:609-613.
36. Esmon CT (1995) Thrombomodulin as a model of molecular mechanisms that modulate protease specificity and function at the vessel surface. FASEB J 9:946-955.
37. Esmon CT (2003) The protein C pathway. Chest 124:26S-32S.
38. Vu TK, Wheaton VI, Hung DT, Charo I, Coughlin SR (1991) Domains specifying thrombin-receptor interaction. Nature 353:674-677.
39. Seeley S, Covic L, Jacques SL, Sudmeier J, Baleja JD, Kuliopulos A (2003) Structural basis for thrombin activation of a protease-activated receptor: Inhibition of intramolecular liganding. Chem Biol 10:1033-1041.
40. Ayala YM, Cantwell AM, Rose T, Bush LA, Arosio D, Di Cera E (2001) Molecular mapping of thrombin-receptor interactions. Proteins 45:107-116.
41. Mathews II, et al. (1994) Crystallographic structures of thrombin complexed with thrombin receptor peptides: Existence of expected and novel binding modes. Biochemistry 33: 3266-3279.
42. Pineda AO, Chen ZW, Bah A, Garvey LC, Mathews FS, Di Cera E (2006) Crystal structure of thrombin in a self-inhibited conformation. J Biol Chem 281:32922-32928.
43. Wells CM, Di Cera E (1992) Thrombin is a Na(+)-activated enzyme. Biochemistry 31:11721-11730.
44. Di Cera E (2003) Thrombin interactions. Chest 124:11S-17S.
45. Esmon CT, Mather T (1998) Switching serine protease specificity. Nat Struct Biol 5:933-937.
46. Kroh HK, Tans G, Nicolaes GAF, Rosing J, Bock PE (2007) Expression of allosteric linkage between the sodium ion binding site and exosite I of thrombin during prothrombin activation. J Biol Chem 282:16095-16104.
47. Lai MT, Di Cera E, Shafer JA (1997) Kinetic pathway for the slow to fast transition of thrombin: Evidence of linked ligand binding at structurally distinct domains. J Biol Chem 272:30275-30282.
48. Parry MA, Stone SR, Hofsteenge J, Jackman MP (1993) Evidence for common structural changes in thrombin induced by active-site or exosite binding. Biochem J 290(Pt 3):665-670.
49. Xu H, Bush LA, Pineda AO, Caccia S, Di Cera E (2005) Thrombomodulin changes the molecular surface of interaction and the rate of complex formation between thrombin and protein C. J Biol Chem 280:7956-7961.
50. Esmon NL, DeBault LE, Esmon CT (1983) Proteolytic formation and properties of gamma-carboxyglutamic acid-domainless protein C. J Biol Chem 258:5548-5553.
51. + binding to thrombin resolved by ultra-rapid kinetics. Biophys Chem 131:111-114.
52. + reveal the basis of monovalent cation selectivity and an inactive slow form. Biophys Chem 121:177-184.
53. + activation but retains high catalytic activity. J Biol Chem 281:7183-7188.
54. + activation mimicry in murine thrombin. J Biol Chem 282:16355-16361.
55. Boehr DD, McElheny D, Dyson HJ, Wright PE (2006) The dynamic energy landscape of dihydrofolate reductase catalysis. Science 313:1638-1642.
56. Hardy JA, Wells JA (2004) Searching for new allosteric sites in enzymes. Curr Opin Struct Biol 14:706-715.
57. Cantwell AM, Di Cera E (2000) Rational design of a potent anticoagulant thrombin. J Biol Chem 275:39827-39830.
58. Gruber A, Cantwell AM, Di Cera E, Hanson SR (2002) The thrombin mutant W215A/E217A shows safe and potent anticoagulant and antithrombotic effects in vivo. J Biol Chem 277:27581-27584.
59. Gruber A, et al. (2007) Relative antithrombotic and antihemostatic effects of protein C activator versus low molecular weight heparin in primates. Blood 109:3733-3740.
60. Pineda AO, et al. (2004) The anticoagulant thrombin mutant W215A/E217A has a collapsed primary specificity pocket. J Biol Chem 279:39824-39828.
61. Otwinowski Z, Minor W (1997) Processing of x-ray diffraction data collected by oscillation methods. Methods Enzymol 276:307-326.
62. Bailey S (1994) The CCP4 suite. Programs for protein crystallography. Acta Crystallogr D Biol Crystallogr 50:760-763.
63. Brunger AT, et al. (1998) Crystallography and NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr 54(Pt 5):905-921.
64. Morris AL, MacArthur MW, Hutchinson EG, Thornton JM (1992) Stereochemical quality of protein structure coordinates. Proteins 12:345-364.